Immune-altered “intermediate” tumors are characterized by the restriction of T cell infiltrate to the surrounding stroma, with production of chemokines and tumor-derived inhibitory factors, such as TGFβ [101]. This evidence concerns the gene TGFB1 and neoplasm.